510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION CHECKLIST

First Page		Document Content
Date: 2009-03-04 13:03:45 Medical tests Drug control law Drug test Employment ELISA Oxycodone Immunoassay Tetrahydrocannabinol Assay Chemistry Immunologic tests Euphoriants		510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION CHECKLIST Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 309,37 KB Share Document on Facebook

	Drug overdose ranks as the leading cause of adult accidental deaths in the U.S. Commonly prescribed opioid pain relievers, like oxycodone and hydrocodone, are involved in more overdose deaths than any other opioid type. DocID: 1tZOQ - View Document
	Prescribing Opioid Painkillers in the Emergency Department For your safety, we do not: Prescribe long-acting opioid pain medication such as oxycodone, extended-release DocID: 1tX5B - View Document
	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use OXAYDO safely and effectively. See full prescribing information for OXAYDO. OXAYDO® (oxycodone HCl, USP) Tablets fo DocID: 1toTP - View Document
	A M TPECNOC EN I EDOC Morphine; Codeine; Hydrocodone; Oxycodone; Levorphanol; Meperidine. . Rods Concept Map · Gram Negative Rods Related With Enteric Tract Concept Map . Concept mapping and mind mapping are used in the DocID: 1sR62 - View Document
	The Role of Controlled-Release Opioids in the Treatment of Chronic Pain Frank B. Fisher, M.D. ABSTRACT Conventional wisdom in the field of pain management assumes that controlled-release formulations of opioid analgesics DocID: 1rcKV - View Document